Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Delia Johnson

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|April 29, 2014
Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemiaThomas Rutledge, Tanya S Kenkre, Diane V Thompson, et al.
Journal of the American College of Cardiology|February 7, 2006
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) StudyGretchen L Gierach, B Delia Johnson, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|June 3, 2004
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation StudyChristopher B Arant, Timothy R Wessel, Marian B Olson, et al.
Journal of Women'S Health (2002)|January 27, 2005
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyB Delia Johnson, C Noel Bairey Merz, Glenn D Braunstein, et al.
Menopause (New York, N.Y.)|September 28, 2016
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)Rebecca C Thurston, B Delia Johnson, Chrisandra L Shufelt, et al.
Journal of Women'S Health (2002)|September 9, 2008
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Leslee J Shaw, C Noel Bairey Merz, Vera Bittner, et al.
Circulation|February 19, 2004
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Gregory O von Mering, Christopher B Arant, Timothy R Wessel, et al.
Circulation|August 23, 2006
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome EvaluationLeslee J Shaw, C Noel Bairey Merz, Carl J Pepine, et al.
Journal of the American Heart Association|September 2, 2017
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation StudyPuja K Mehta, B Delia Johnson, Tanya S Kenkre, et al.
Clinical Cardiology|May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChristopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|April 29, 2014
Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemiaThomas Rutledge, Tanya S Kenkre, Diane V Thompson, et al.
Journal of the American College of Cardiology|February 7, 2006
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) StudyGretchen L Gierach, B Delia Johnson, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|June 3, 2004
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation StudyChristopher B Arant, Timothy R Wessel, Marian B Olson, et al.
Journal of Women'S Health (2002)|January 27, 2005
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyB Delia Johnson, C Noel Bairey Merz, Glenn D Braunstein, et al.
Menopause (New York, N.Y.)|September 28, 2016
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)Rebecca C Thurston, B Delia Johnson, Chrisandra L Shufelt, et al.
Journal of Women'S Health (2002)|September 9, 2008
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Leslee J Shaw, C Noel Bairey Merz, Vera Bittner, et al.
Circulation|February 19, 2004
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Gregory O von Mering, Christopher B Arant, Timothy R Wessel, et al.
Circulation|August 23, 2006
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome EvaluationLeslee J Shaw, C Noel Bairey Merz, Carl J Pepine, et al.
Journal of the American Heart Association|September 2, 2017
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation StudyPuja K Mehta, B Delia Johnson, Tanya S Kenkre, et al.
Clinical Cardiology|May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChristopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
Pageof 9